Pseudo-Cushing Syndrome Caused by Fenofibrate Interference with Urinary Cortisol Assayed by High-Performance Liquid Chromatography
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Urinary free cortisol (UFC) excretion over 24 h reflects the production rate of cortisol and is used commonly in the diagnosis of Cushing syndrome. We report on two patients evaluated for Cushing syndrome who had elevated UFC when analyzed by HPLC but normal values for the analysis performed by RIA and HPLC-mass spectrometry/mass spectrometry (HPLC-MS/MS). Other laboratory testing was inconsistent with the diagnosis of Cushing syndrome and raised doubts about the diagnosis. We identified a probable cause of analytical interference as coming from fenofibrate (Tricor), medication taken by the patients. Fenofibrate peak overlapped with the HPLC peak of cortisol and produced an MS/MS transition overlapping the major transition of cortisol. A second MS/MS transition was free from interference. In summary, fenofibrate administration may cause false elevation of UFC values determined by HPLC or HPLC-MS/MS in patients evaluated for Cushing syndrome. An HPLC-MS/MS method using multiple mass transitions, rather than a single transition, allows accurate quantitation of urinary cortisol in patients taking fenofibrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Newer diagnostic techniques and problems in Cushing’s disease
Findling, J. W., & Raff, H. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70063-3 · Cited by 97
Self-citation
Research works printed but not linked: 17
- Liddle, 1960, Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome., J Clin Endocrinol Metab, 20, 1539, 10.1210/jcem-20-12-1539 · DOI · Paper page
- Meikle, 1986, Laboratory tests for the diagnosis of Cushing’s syndrome and adrenal insufficiency and factors affecting those tests, In: DeGroot L, Cahill G, Potts J, Nelson DH, Winegard A, Martini L, eds. Endocrinology. New York: Grune, Stratton, Inc.;, 1157
- Mengden, 1992, Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing’s syndrome., Clin Investig, 70, 545, 10.1007/BF00184788 · DOI
- Meikle, 1993, A diagnostic approach to Cushing’s syndrome., Endocrinologist, 3, 311, 10.1097/00019616-199309000-00003 · doi:10.1097/00019616-199309000-00003
- Findling, 1994, Biochemical and radiologic diagnosis of Cushing’s syndrome., Endocrinol Metab Clin North Am, 23, 511, 10.1016/S0889-8529(18)30081-1 · DOI
- Meikle, 1969, Urinary cortisol excretion determined by competitive protein-binding radioassay: a test of adrenal cortical function., J Lab Clin Med, 74, 803
- Contreras, 1986, Urinary cortisol in the assessment of pituitary-adrenal function: utility of 24-hour and spot determinations., J Clin Endocrinol Metab, 62, 965, 10.1210/jcem-62-5-965 · DOI
- McWhinney, 1996, Improved HPLC method for simultaneous analysis of cortisol, 11-deoxycortisol, prednisolone, methylprednisolone, and dexamethasone in serum and urine., Clin Chem, 42, 979, 10.1093/clinchem/42.6.979 · DOI
- Turpeinen, 1997, Determination of urinary free cortisol by HPLC., Clin Chem, 43, 1386, 10.1093/clinchem/43.8.1386 · DOI
- Findling, 1998, Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine., Endocrinologist, 8, 51, 10.1097/00019616-199803000-00001 · DOI · Paper page
- Kushnir, 2003, Urinary free cortisol analysis by LC-MS/MS., Clin Chem, 49, 965, 10.1373/49.6.965 · DOI
- Henry, 1996, Clinical diagnosis and management by laboratories
- Taylor, 2002, Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone., Clin Chem, 48, 1511, 10.1093/clinchem/48.9.1511 · DOI · Paper page
- Mengden, 1992, Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing’s syndrome., Clin Investig, 70, 545, 10.1007/BF00184788 · DOI
- Nieman, 2002, Diagnostic tests for Cushing’s syndrome., Ann NY Acad Sci, 970, 112, 10.1111/j.1749-6632.2002.tb04417.x · DOI · Paper page
- Flack, Ann Intern Med, 116, 211, 10.7326/0003-4819-116-3-211 · DOI · Paper page
- Kaye, 1990, The Cushing syndrome: an update on diagnostic tests., Ann Intern Med, 112, 434, 10.7326/0003-4819-76-3-112-6-434 · DOI · Paper page
Cited by
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Cushing’s Syndrome: important issues in diagnosis and management
Findling, J. W., & Raff, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0997 · Cited by 294
Self-citationA physiologic approach to diagnosis of the Cushing syndrome.
Raff, H., & Findling, J. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00010 · Cited by 186
Self-citationRaff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141
Metadata
- Authors
- Meikle, A. W., Findling, J., Kushnir, M. M., Rockwood, A. L., Nelson, G. J., & Terry, A. H.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 88
- Issue
- 8
- Pages
- 3521-3524
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126278562
- Cited by
- 63
- References
- 1
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pseudo-Cushing Syndrome Caused by Fenofibrate Interference with Urinary Cortisol Assayed by High-Performance Liquid Chromatography. https://app.cochat.ai/papers/10.1210/jc.2003-030234
- The paper
- Meikle, A. W., Findling, J., Kushnir, M. M., Rockwood, A. L., Nelson, G. J., & Terry, A. H. (2003). Pseudo-Cushing Syndrome Caused by Fenofibrate Interference with Urinary Cortisol Assayed by High-Performance Liquid Chromatography. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-030234
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.